Table 2 Characteristics of patients with NSCLC
From: Elucidating the role of EPPK1 in lung adenocarcinoma development
Characteristic | N | All, N = 295 |
|---|---|---|
Age | 294 | 66 (60–72) |
Gender | 294 | |
Female | 121 (41.2%) | |
Male | 173 (58.8%) | |
Smoking history | 292 | |
Ever | 267 (91.4%) | |
Never | 25 (8.6%) | |
Histology | 295 | |
LUAD | 140 (47.5%) | |
LUSC | 155 (52.5%) | |
Stage | 295 | |
I | 114 (38.6%) | |
II | 44 (14.9%) | |
III | 93 (31.5%) | |
IV | 44 (14.9%) | |
COPD | 237 | 96 (40.5%) |
EPPK1 | 280 | 140 (50.0%) |
Low | 140 (50.0%) | |
High | 140 (50.0%) | |
Median (25%-75%); n (%) | ||